Bavencio - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

News

UK trial to evaluate existing drugs for secondary breast cancer

A new UK-based clinical trial will evaluate existing cancer drugs as potential treatments for women living with metastatic breast cancer. The study, led by Profes...

29 September 2021 News Bavencio | breast cancer

Continue Reading →

News

SMC approves Bavencio for bladder cancer

Merck and Pfizer’s Bavencio (avelumab) has been approved by the Scottish Medicines Consortium (SMC) for use via NHS Scotland as a first-line maintenance treatment fo...